ResearcherAnhui Medical UniversityNo recent work listed
Yue Zhao
Matched on ORCID iD 0000-0002-2721-1372; OpenAlex author ID A5100659245. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 4
2013: 2 papers · 2014: 1 paper
Papers 3
- [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma]. Co-author PMID 25331466↗
- Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00432-013-1422-4↗
- Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s12032-013-0583-y↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ren-bao Yang · 3 shared papers, 2013–2014 · strength 0.12
- Paper [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma]. PMID 25331466↗
- Paper Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma. DOI 10.1007/s00432-013-1422-4↗
- Paper Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma. DOI 10.1007/s12032-013-0583-y↗
- Jiong Chen · 3 shared papers, 2013–2014 · strength 0.12
- Paper [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma]. PMID 25331466↗
- Paper Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma. DOI 10.1007/s00432-013-1422-4↗
- Paper Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma. DOI 10.1007/s12032-013-0583-y↗
- Longjiang Chen · 3 shared papers, 2013–2014 · strength 0.12
- Paper [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma]. PMID 25331466↗
- Paper Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma. DOI 10.1007/s00432-013-1422-4↗
- Paper Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma. DOI 10.1007/s12032-013-0583-y↗
- Liwei Hu · 3 shared papers, 2013–2014 · strength 0.12
- Paper [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma]. PMID 25331466↗
- Paper Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma. DOI 10.1007/s00432-013-1422-4↗
- Paper Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma. DOI 10.1007/s12032-013-0583-y↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.